Dexanabinol in Patients With Brain Cancer

NCT01654497 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

26

Enrollment

OTHER

Sponsor class

Conditions

Brain Cancer

Interventions

DRUG: Dexanabinol

Sponsor

Santosh Kesari, M.D., Ph.D.

Collaborators

[object Object]